Generalao, Xandra .

HRN: 27-08-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
CEFUROXIME 750MG (VIAL)
05/08/2025
05/15/2025
IV
300mg
Q8
T/c Uti
Waiting Final Action 
05/10/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/10/2025
05/17/2025
PO
3ml
TID
Acute Infectious Diarrhea
Waiting Final Action 
05/11/2025
CEFTRIAXONE 1G (VIAL)
05/11/2025
05/18/2025
IV
800mg
Q24
Typhoid Fever
Waiting Final Action 
05/12/2025
MUPIROCIN 2%, 15G (TUBE)
05/12/2025
05/19/2025
TOPICAL
-
2x A Day
Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: